David H. Koch has come to be as renowned for his visionary philanthropic support of cancer research as he is for his business prominence.
Just as David applied his natural intellect and MIT education to his work at Koch Industries, helping it grow into one of the largest privately held companies in the world, similarly he has approached his philanthropy by educating himself in current cancer science and research and applying that knowledge to his charitable giving decisions. David has become a passionate supporter of many of the greatest cancer centers in the U.S. committing over $500 million for basic cancer research with a particular focus on prostate cancer. David has directed his generosity toward basic research because he believes that such investigation will open new pathways to cures for cancer.
David’s recent donations include $20 million to Johns Hopkins University’s medical campus in Baltimore, that resulted in the naming of the new David H. Koch Cancer Research Building, and $100 million to MIT to create the David H. Koch Institute for Integrative Cancer Research. David serves on more than 20 nonprofit boards, including the board of the Memorial Sloan-Kettering Cancer Center.
David’s leadership and steadfast commitment have raised awareness of the need for philanthropic support of basic research and have inspired others to join his efforts.
